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MicroorganismsAbstract The symmetrical bisheterocycles built around varying lengths aliphatic linkers have been
synthesized from the easy cyclization reactions of bischalcones with phenyl hydrazine by reﬂuxing
in dry EtOH and glacial acetic acid medium. The intermediates in turn were prepared in the good
yields from O-alkylation of hydroxy substituted chalcone with suitable 1,x-dibromoalkanes in the
presence of anhydrous K2CO3, dry acetone and Bu4N
+I as PTC. The chalcone was obtained from
the Claisen–Schmidt condensation reaction of p-hydroxyacetophenone with 2-furfuraldehyde. The
structures of bischalcones and bispyrazolines were fully characterized by using various spectro-
scopic techniques including IR, 1H NMR, 13C NMR & Mass (ESI) and purity of these products
were conﬁrmed from their elemental analysis results. The newly prepared compounds were also
screened for their antimicrobial activities against seven bacterial and ﬁve fungal strains by using
serial tube dilution method. Some of the compounds exhibited signiﬁcant activities against the
tested microorganisms.
ª 2015 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Five membered heterocyclic compounds containing two nitro-
gen atoms such as substituted pyrazolines [1–3] have played a
vital role in discovering novel compounds exhibiting various
biological activities such as antitumor [4], anti-inﬂammatory
[5–7], MAO-B inhibitors [8,9], agonist of cannabinoid receptors
[10], antioxidant [11–13], antihypertensive [14], anticancer [15–20], antidepressant [21–23], antiamoebic [24] and as CB2 recep-
tor [25]. Recently these compounds are also reported to possess
potential antiviral activity against ﬂavivirus [26] and HIV [27].
Among these heterocycles, 2-pyrazolines display a broad spec-
trum of potential pharmacological activities [28–
30,6,31,7,5,32–42] and are present in a number of drug mole-
cules such as phenazone [43] 1 (anti-inﬂammatory and antipyre-
tic), methampyrone [44] 2 (analgesic and antipyretic), azolid [45]
3 (anti-inﬂammatory), tandearil [46] 4 (anti-inﬂammatory) &
anturan [47] 5 (uricosuric), etc (Figure 1). These compounds
are prepared by the cyclization reaction of chalcones with
hydrazine derivatives [48]. A number of applications such as
dyestuff’s analytical reagents [49] and agrochemicals [50] are
also found to be associated with the chalcones. Keeping these
synthetic applications in mind and inspired by our previous
researches on bisheterocyclics [51–53], we report herein theurnal of
2 M. Yusuf, I. Solankisynthesis of new bischalcones 8(a–h) built around aliphatic
chain of varying lengths and their transformations to
bispyrazolines 9(a–h). The major interest behind this study
was to study the effect of internal methylene chain length upon
the synthesis and antimicrobial behavior of new bisheterocyles.
2. Experimental
Melting points reported are uncorrected. IR spectra were
scanned in KBr pellets on a Perkin Elmer RXIFT Infrared
spectrophotometer. 1H NMR spectra were recorded on a
400 MHz Bruker spectrometer using TMS as the internal stan-
dard. The mass spectra have been scanned on the Waters
Micromass Q–T of Micro (ESI) spectrometer. TLC plates were
coated with silica gel suspended in MeOH–CHCl3 and iodine
vapors were used as a visualizing agent.
2.1. Synthesis of (2E)-3-(furan-2-yl)-1-(4-
hydroxyphenyl)prop-2-en-1-one 7
A solution of p-hydroxy-acetophenone (5.0 g, 0.0036 mol), 2-
furaldehyde (3.5 g, 0.0036 mol) and NaOH (3.6 g, 0.091 mol)
in ethanol (25.0 mL) was stirred in an ice bath for 10 h.
During the course of reaction, the initially formed yellow mix-
ture changed to a reddish gummy mass. The resulting mass
was poured into iced-HCl to yield a green solid that was ﬁltered,
thoroughly washed with water and dried. The crude product
was crystallized from MeOH to provide green needles of 7.
7: Green solid; Yield 82%; m.p.: 170–172 C; IR (KBr)
cm1: 3260 (OH), 1656 (C‚O), 1604 (C‚C); 1H NMR
(400 MHz, CDCl3): d 10.11 (1H, s, OH), 7.93 (2H, d,
Jo = 8.7 Hz, H-2
0, 60), 7.53 (1H, d, Jtrans = 15.3 Hz, H-3),
7.47 (1H, d, Jtrans = 15.4 Hz, H-2), 7.65 (1H, d,
J300,400 = 1.0 Hz, H-3
00), 6.90 (2H, d, Jo = 8.7 Hz, H-30, 50),
6.83 (1H, d, J500,400 = 3.3 Hz, H-5
00), 6.55 (1H, dd,
J400,300 = 1.7 Hz, J400,500 = 3.3 Hz, H-4
00); 13C NMR (100 MHz,
CDCl3): d 195.74 (C‚O), 162.13 (C-200), 151.28 (C-40),
145.45 (C-3), 130.74 (C-10), 130.54 (C-300), 129.28 (C-20, 60),
118.79 (C-500), 115.96 (C-30, 50), 115.37 (C-2), 112.77 (C-400);
MS(ESI): (M+1)+ = 215; Anal. Calc. for C13H10O3: C,
72.89; H, 4.67; Found C, 73.16; H, 4.65%.
2.2. Synthesis of (2E,20E)-1,10-(4,40-ethane–1,2-
diylbis(oxy))bis(4,1-phenylene)bis(3-furan-2-yl)prop-2-en-1-
one 8a
A suspension of chalcone (2.14 g, 0.01 mol), 1,2-dibro-
moethane (0.93 g, 0.005 mol) and tetrabutylammonium iodide
(1.0 g) and anhydrous K2CO3 in dry acetone (25 mL) was
reﬂuxed for 6 h with continuous stirring. The progress of reac-
tion was monitored by TLC. After the completion of reaction,
the reaction mixture turned to a colorless mass which was
poured into iced-HCl to obtain a crude product that was crys-
tallized with MeOH to yield a pure bischalcone 8a.
8a: Cream solid; Yield 52%; m.p.: 128–130 C; IR (KBr)
cm1: 2955, 2870 (methylene CAH), 1652 (C‚O), 1605
(C‚C) & 1225, 1010 (CAO); 1H NMR (400 MHz, CDCl3): d
8.05 (4H, dd, Jm,o = 2.9, 8.8 Hz, H-2
0, 60), 7.62 (2H, d,
J300,400 = 1.3 Hz, H-3
00), 7.56 (2H, d, Jtrans = 15.3 Hz, H-3),
7.49 (2H, d, Jtrans = 15.3 Hz, H-2), 7.05 (4H, d, Jo = 8.3 Hz,
H-30, 50), 6.83 (2H, d, J500,400 = 3.4 Hz, H-500), 6.55 (2H, dd,Please cite this article in press as: M. Yusuf, I. Solanki, Synthesis and antimicrobial
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00), 4.47 (4H, s, OCH2);
13C NMR (100 MHz, CDCl3): d 186.62 (C‚O), 162.28 (C-200),
151.32 (C-40), 144.69 (C-3), 132.24 (C-20, 60), 130.68 (C-10),
129.86 (C-300), 118.46 (C-500), 115.72 (C-30, 50), 114.38 (C-2),
112.60 (C-400), 69.58 (OCH2); (MS-ESI): m/z (M+1)
+ 455;
Anal. Calc. for C28H22O6: C, 74.00; H, 4.84; Found C, 74.26;
H, 4.82%.
2.3. Synthesis of (2E,20E)-1,10-(4,40-propane-1,3-
diylbis(oxy))bis(4,1-phenylene)bis(3-furan-2-yl)prop-2-en-1-
one 8b
The bischalcone 8b was obtained from the reaction of chalcone
2 (2.14 g, 0.01 mol) with 1,3-dibromopropane (1.00 g,
0.005 mol) under the similar conditions as described above
for 8a.
8b: Light yellow solid; Yield 58%; m.p.:77–80 C; IR (KBr)
cm1: 2928, 2872 (methylene CAH), 1659 (C‚O), 1605
(C‚C) & 1229, 1010 (CAO); 1H NMR (400 MHz, CDCl3):
d 8.04 (4H, d, Jo = 8.8 Hz, H-20, 60), 7.79 (2H, brs, H-300),
7.55 (2H, d, Jtrans = 15.3 Hz, H-3), 7.49 (2H, d,
Jtrans = 15.3 Hz, H-2), 7.08 (4H, d, Jo = 8.8 Hz, H-3
0, 50),
6.92 (2H, d, J500,400 = 3.4 Hz, H-5
00), 6.62 (2H, dd,
J400,300 = 1.8 Hz, J400,500 = 3.2 Hz, H-4
00), 4.26 (4H, t,
Jvic = 6.1 Hz, OCH2), 2.27 (2H, quintet, Jvic = 6.2 Hz,
OCH2CH2);
13C NMR (100 MHz, CDCl3): d 188.06 (C‚O),
162.62 (C-200), 151.70 (C-40), 144.77 (C-3), 132.47 (C-20, 60),
130.57 (C-10), 129.99 (C-300), 118.15 (C-500), 15.83 (C-30, 50),
114.15 (C-2), 112.61 (C-400), 69.52 (OCH2CH2), 29.26
(OCH2CH2); (MS-ESI): m/z (M+1)
+ 469; Anal. Calc. for
C29H24O6: C, 74.36; H, 5.12; Found C, 74.12; H, 5.13%.
2.4. Synthesis of (2E,20E)-1,10-(4,40-butane-1,4-
diylbis(oxy))bis(4,1-phenylene)bis(3-furan-2-yl)prop-2-en-1-
one 8c
The bischalcone 8c was synthesized from the reaction of chal-
cone 7 (2.14 g, 0.01 mol) with 1,4-dibromobutane (1.07 g,
0.005 mol) under the similar conditions as discussed earlier
for 8a.
8c: Light brown solid; Yield 70%; m.p.: 128–130 C; IR
(KBr) cm1: 2928, 2872 (methylene CAH), 1655 (C‚O), 1605
(C‚C) & 1226, 1018 (CAO); 1H NMR (400 MHz, CDCl3): d
8.03 (4H, dd, Jm,o = 2.7, 8.8 Hz, H-2
0, 60), 7.69 (2H, brs, H-
300), 7.55 (2H, d, Jtrans = 15.3 Hz, H-3), 7.50 (2H, d, Jtrans =
15.4 Hz, H-2), 7.03 (4H, d, Jo = 8.8 Hz, H-3
0, 50), 6.88 (2H, d,
J500,400 = 3.4 Hz, H-5
00), 6.58 (2H, dd, J400,300 = 1.7 Hz,
J400,500 = 3.2 Hz, H-4
00), 4.16 (4H, brs, OCH2), 2.00 (4H, brs,
OCH2CH2);
13C NMR (100 MHz, CDCl3): d 188.08 (C‚O),
163.67 (C-200), 151.87 (C-400), 144.66 (C-3), 130.85 (C-20, 60),
130.74 (C-10), 129.92 (C-300), 119.26 (C-500), 115.73 (C-30, 50),
114.30 (C-2), 112.59 (C-400), 68.25 (OCH2CH2), 29.33
(OCH2CH2); (MS-ESI): m/z (M+Na)
+ 505; Anal. Calc. for
C30H26O6: C, 74.68; H, 5.39; Found C, 74.89; H, 5.41%.
2.5. Synthesis of (2E,20E)-1,10-(4,40-pentane-1,5-diylbis(oxy))
bis(4,1-phenylene)bis(3-furan-2-yl)prop-2-en-1-one 8d
The bischalcone 8dwas prepared by reacting chalcone 7 (2.14 g,
0.01 mol) with 1,5-dibromopentane (1.14 g, 0.005 mol) under
the similar conditions as explained earlier for 8a.studies of furyl based new bispyrazolines linked via aliphatic chains, Journal of
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cm1: 2950, 2877 (methylene CAH), 1658 (C‚O), 1606
(C‚C) & 1229, 1018 (CAO); 1H NMR (400 MHz, DMSO-
d6): d 8.01 (4H, d, Jo = 8.7 Hz, H-20, 60), 7.68 (2H, d,
J300,400 = 1.2 Hz, H-3
00), 7.54 (2H, d, Jtrans = 15.3 Hz, H-3),
7.49 (2H, d, Jtrans = 15.4 Hz, H-2), 7.00 (4H, d, Jo = 8.8 Hz,
H-30, 50), 6.87 (2H, d, J500,400 = 3.3 Hz, H-500), 6.57 (2H, dd,
J400,300 = 1.8 Hz, J400,500 = 3.3 Hz, H-4
00), 4.10 (4H, t,
Jvic = 6.3 Hz, OCH2), 1.91 (4H, quintet, Jvic = 7.0 Hz,
OCH2CH2), 1.68 (2H, quintet, Jvic = 5.2 Hz,
OCH2CH2CH2);
13C NMR (100 MHz, DMSO-d6): d 186.65
(C‚O), 162.38 (C-200), 151.04 (C-40), 144.79 (C-3), 130.15
(C-20, 60), 130.11(C-10), 129.32 (C-300), 118.49 (C-500), 115.61
(C-30, 50), 113.94 (C-2), 112.37 (C-400), 67.45 (OCH2), 28.16
(OCH2CH2), 22.01 (OCH2CH2CH2); (MS-ESI): m/z
(M+1)+ 497; Anal. Calc. for C31H28O6: C, 75.00; H, 5.64;
Found C, 75.18; H, 5.61%.
2.6. Synthesis of (2E,20E)-1,10-(4,40-hexane-1,6-
diylbis(oxy))bis(4,1-phenylene)bis(3-furan-2-yl)prop-2-en-1-
one 8e
The bischalcone 8e was obtained from the reaction of chalcone
7 (2.14 g, 0.01 mol) with 1,6-dibromohexane (1.22 g,
0.005 mol) under the similar conditions as described above
for 8a.
8e: Yellow solid; Yield 63%; m.p.: 98–100 C. IR (KBr)
cm1: 2956, 2872 (methylene CAH), 1659 (C‚O), 1604
(C‚C), 1229, 1017 (CAO); 1H NMR (400 MHz, DMSO-d6):
d 8.04 (4H, dd, Jm,o = 2.6, 8.8 Hz, H-20, 60), 7.59 (2H, d,
Jtrans = 15.3 Hz, H-3), 7.52 (2H, d, J300,400 = 1.4 Hz, H-3
00),
7.48 (2H, d, Jtrans = 15.3 Hz, H-2), 6.98 (4H, dd, Jm,o = 2.6,
8.9 Hz, H-30, 50), 6.70 (2H, d, J500,400 = 3.4 Hz, H-500), 6.51
(2H, dd, J400,300 = 1.8 Hz, J400,500 = 3.4 Hz, H-4
00) 4.05 (4H, t,
Jvic = 6.4 Hz, OCH2), 1.87 (4H, quintet, Jvic = 6.4 Hz,
OCH2CH2), 1.73 (4H, m, OCH2CH2CH2);
13C NMR
(100 MHz, DMSO-d6): d 188.06 (C‚O), 162.06 (C-200),
151.79 (C-40), 144.71 (C-3), 130.88 (C-20, 60), 130.72 (C-10),
129.92 (C-300), 119.21 (C-500), 115.75 (C-30, 50), 114.28 (C-2),
112.60 (C-400), 68.05 (OCH2), 29.03 (OCH2CH2), 25.78
(OCH2CH2CH2); (MS-ESI): m/z (M+1)
+ 511; Anal. Calc.
for C32H30O6: C, 75.29; H, 5.88; Found C, 74.98; H, 5.90%.
2.7. Synthesis of (2E,20E)-1,10-(4,40-octane-1,8-
diylbis(oxy))bis(4,1-phenylene)bis(3-furan-2-yl)prop-2-en-1-
one 8f
The bischalcone 8f was synthesized by reacting chalcone 7
(2.14 g, 0.01 mol) with 1,8-dibromoocttane (1.36 g,
0.005 mol) under the similar conditions as explained earlier
for 8a.
8f: Yellow solid; Yield 72%; m.p.: 88–90 C. IR (KBr)
cm1: 2940, 2855 (methylene CAH), 1654 (C‚O), 1597
(C‚C) & 1233, 1021 (CAO); 1H NMR (400 MHz, CDCl3):
d 8.03 (4H, dd, Jm,o = 2.8, 4.7, 9.7 Hz, H-20, 60), 7.57 (2H, d,
Jtrans = 15.3 Hz, H-3), 7.52 (2H, d, J300,400 = 3.5 Hz, H-3),
7.48 (2H, d, Jtrans = 15.3 Hz, H-2), 6.95 (4H, ddd, J= 2.7,
4.7, 9.7 Hz, H-30, 50), 6.69 (2H, d, J500,400 = 3.4 Hz, H-500),
6.50 (2H, dd, J400,300 = 1.8 Hz, J400,500 = 3.4 Hz, H-4
00), 4.04
(4H, t, Jvic = 6.5 Hz, OCH2), 1.82 (4H, quintet,
Jvic = 6.3 Hz, OCH2CH2), 1.41 (4H, quintet, Jvic = 6.3 Hz,Please cite this article in press as: M. Yusuf, I. Solanki, Synthesis and antimicrobial s
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OCH2CH2CH2CH2);
13C NMR (100 MHz, CDCl3): d 186.59
(C‚O), 162.58 (C-200), 151.21 (C-40), 145.35 (C-3), 130.40
(C-20, 60), 130.22 (C-10), 129.50 (C-300), 118.60 (C-500), 116.01
(C-30, 50), 114.17 (C-2), 112.38 (C-400), 67.76 (OCH2), 28.70
(OCH2CH2), 24.43 (OCH2CH2CH2), 25.42
(OCH2CH2CH2CH2); (MS-ESI): m/z (M+1)
+ 539; Anal.
Calc. for C34H34O6: C, 75.84; H, 6.32; Found C, 76.09; H,
6.30%.
2.8. Synthesis of (2E,20E)-1,10-(4,40-decane-1,10-
diylbis(oxy))bis(4,1-phenylene)bis(3-furan-2-yl)prop-2-en-1-
one 8g
The bischalcone 8g was obtained from the reaction of chalcone
7 (2.14 g, 0.01 mol) with 1,10-dibromodecane (1.50 g,
0.005 mol) under the similar conditions as explained earlier
for 8a.
8g: Yellow solid; Yield 64%; m.p.: 77–80 C. IR (KBr)
cm1: 2920, 2852 (methylene CAH), 1653 (C‚O), 1605
(C‚C) & 1231, 1018 (CAO); 1H NMR (400 MHz, DMSO-
d6): d 8.03 (4H, ddd, Jm,o = 2.8, 4.6, 9.8 Hz, H-20, 60), 7.57
(2H, d, Jtrans = 15.3 Hz, H-3), 7.51 (2H, d, J300,400 = 1.5 Hz,
H-300), 7.47 (2H, d, Jtrans = 15.3 Hz, H-2), 6.95 (4H, dd,
J= 2.7, 4.6 Hz, H-30, 50), 6.69 (2H, d, J500,400 = 3.4 Hz, H-500),
6.50 (2H, dd, J400,300 = 1.8 Hz, J400,500 = 3.5 Hz, H-4
00), 4.03
(4H, t, Jvic = 6.5 Hz, OCH2), 1.83 (4H, quintet,
Jvic = 6.7 Hz, OCH2CH2), 1.47 (4H, quintet, Jvic = 6.6 Hz,
OCH2CH2CH2), 1.31 (8H, m, OCH2CH2CH2CH2CH2);
13C
NMR (100 MHz, CDCl3): d 187.73 (C‚O), 163.54 (C-200),
151.35 (C-40), 145.06 (C-3), 130.73 (C-20, 60), 130.16 (C-10),
129.48 (C-300), 118.56 (C-500), 115.68 (C-30, 50), 113.78 (C-2),
112.64 (C-400), 67.69 (OCH2), 28.63 (OCH2CH2), 25.38
(OCH2CH2CH2), 24.42 (OCH2CH2CH2CH2), 23.73
(OCH2CH2CH2CH2CH2); (MS-ESI): m/z (M+1)
+ 567;
Anal. Calc. for C36H38O6: C, 76.32; H, 6.71; Found C,
76.14; H, 6.69%.
2.9. Synthesis of (2E,20E)-1,10-(4,40-dodecane-1,12-
diylbis(oxy))bis(4,1-phenylene)bis(3-furan-2-yl)prop-2-en-1-
one 8h
The bischalcone 8h was synthesized by reacting chalcone 7
(2.14 g, 0.01 mol) with 1,12-dibromododecane (1.64 g,
0.005 mol) under the similar conditions as explained earlier
for 8a.
8h: Yellow solid; Yield 78%; m.p.: 77–80 C; IR (KBr)
cm1: 2936, 2850 (methylene CAH), 1655 (C‚O), 1601
(C‚C) & 1255, 1027 (CAO); 1H NMR (400 MHz, CDCl3):
d 8.02 (4H, d, Jo = 8.8 Hz, H-20, 60), 7.70 (2H, d,
J300,400 = 1.4 Hz, H-3
00), 7.54 (2H, d, Jtrans = 15.4 Hz, H-3),
7.49 (2H, d, Jtrans = 15.4 Hz, H-2), 7.00 (4H, d, Jo = 8.8 Hz,
H-30, 50), 6.88 (2 H, d, J500,400 = 3.4 Hz, H-500), 6.58 (2H, dd,
J400,300 = 1.8 Hz, J400,500 = 3.3 Hz, H-4
00), 3.98 (4H, t,
Jvic = 6.5 Hz, OCH2), 1.89 (4H, quintet, Jvic = 6.7 Hz,
OCH2CH2), 1.43 (4H, quintet, Jvic = 6.6 Hz,
OCH2CH2CH2), 1.29 (4H, m, OCH2CH2CH2CH2), 1.24 (8H,
m, OCH2CH2CH2CH2CH2CH2);
13C NMR (100 MHz,
DMSO-d6): d 186.57 (C‚O), 162.47 (C-200), 151.07 (C-40),
144.91 (C-3), 130.18 (C-20, 60), 130.04 (C-10), 129.32 (C-300),
118.51 (C-500), 115.68 (C-30, 50), 113.96 (C-2), 112.42 (C-400),tudies of furyl based new bispyrazolines linked via aliphatic chains, Journal of
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22.06 (OCH2CH2CH2CH2), 19.47 (OCH2CH2CH2CH2CH2),
17.28 (OCH2CH2CH2CH2CH2CH2); (MS-ESI): m/z
(M+Na)+ 617; Anal. Calc. for C38H42O6: C, 76.77; H, 7.07;
Found C, 76.58; H, 7.09%.
2.10. Synthesis of 1-(4-((R)-5-(furan-2-yl)-1-phenyl-4,5-
dihydro-1H-pyrazol-3-yl)phenoxy)-2-(4-((S)-5-(furan-2-yl)-
1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)ethane 9a
A mixture of bischalcone 8a (1.0 g, 0.002 mol), phenyl hydra-
zine (0.47 g, 0.004 mol) and AcOH (5 mL) and EtOH
(25 mL) was reﬂuxed for 6 h. The progress of reaction was
monitored by TLC. After the completion of reaction, the reac-
tion mixture was concentrated under reduced pressure and
resulting mass was cooled in an ice bath to yield a solid pro-
duct which was further recrystallized from MeOH to give pure
bispyrazoline 9a.
9a: Light yellow solid; Yield 54%; m.p.: 77–80 C; IR
(KBr) cm1: 2932, 2866 (methylene CAH), 1597 (C‚N) &
1246, 1016 (CAO); 1H NMR (DMSO-d6): d 7.64 (4H, dd,
Jm,o = 4.9, 7.6 Hz, H-2
0, 60), 7.47 (2H, brs, H-300), 7.19 (4H,
td, J= 4.9, 8.5 Hz, H-3000, 5000), 7.09 (4H, dd, J= 2.8, 8.4 Hz,
H-2000, 6000), 6.98 (4H, d, Jo = 8.7 Hz, H-30, 50), 6.76 (2H, m,
H-500), 6.39 (4H, m, H-400, 4000), 5.53 (2H, dd, JXA = 6.3 Hz,
JXM = 12.2 Hz, H-X), 3.76 (2H, dd, JMX = 12.2 Hz,
JMA = 17.2 Hz, H-M), 3.38 (2H, dd, JAX = 5.8 Hz,
JAM = 16.7 Hz, H-A), 4.21 (4H, s, OCH2);
13C NMR
(100 MHz, DMSO-d6): d 159.18 (C-200), 153.27 (C-40), 146.98
(C‚N), 144.62 (C-1000), 142.14 (C-10), 128.72 (C-20, 60),
127.38 (C-300), 124.79 (C-3000, 5000), 118.62 (C-500), 116.67 (C-
4000), 114.39 (C-30, 50), 110.28 (C-2000, 6000), 106.98 (C-400), 67.98
(OCH2), 56.82 (C-4), 42.69 (C-5); (MS-ESI): m/z (M+1)
+
635; Anal. Calc. for C40H34O4N4: C, 75.71; H, 5.36; N, 8.83;
Found C, 75.59; H, 5.35; N, 8.86%.
2.11. Synthesis of 1-(4-((R)-5-(furan-2-yl)-1-phenyl-4,5-
dihydro-1H-pyrazol-3-yl)phenoxy)-3-(4-((S)-5-(furan-2-yl)-
1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)propane 9b
The compound 9b was synthesized from the reaction of bis-
chalcone 8b (1.0 g, 0.002 mol) with phenyl hydrazine (0.46 g,
0.004 mol) under similar conditions as discussed earlier for 9a.
9b: Light yellow solid; Yield 62%; m.p.: 92–95 C; IR (KBr)
cm1: 2928, 2856 (methylene CAH), 1597 (C‚N) & 1244, 1013
(CAO); 1H NMR (400 MHz, DMSO-d6): d 7.68 (4H, dd,
Jm,o = 4.9, 7.8 Hz, H-2
0, 60), 7.49 (2H, brs, H-300), 7.17 (4H, td,
J= 4.9, 8.5 Hz, H-3000, 5000), 7.06 (4H, dd, Jo = 2.8, 8.4 Hz, H-
2000, 6000), 7.00 (4H, d, Jo = 8.7 Hz, H-30, 50), 6.70 (2H, m, H-
500), 6.38 (4H, m, H-400, 4000), 5.49 (2H, dd, JXA = 6.1 Hz,
JXM = 12.0 Hz, H-X), 4.21 (4H, t, Jvic = 6.1 Hz, OCH2), 3.73
(2H, dd, JMX = 12.2 Hz, JMA = 17.2 Hz, H-M), 3.33 (2H, dd,
JAX = 5.8 Hz, JAM = 16.7 Hz, H-A), 2.23 (2H, quintet,
Jvic = 6.0 Hz, OCH2CH2);
13C NMR (100 MHz, DMSO-d6):
d 159.04 (C-200), 153.25 (C-40), 147.18 (C‚N), 144.70 (C-1000),
142.18 (C-10), 128.51 (C-20, 60), 127.03 (C-300), 124.75 (C-3000,
5000), 118.53 (C-500), 116.53 (C-4000), 114.36 (C-30, 50), 110.17 (C-
2000, 6000), 107.18 (C-400), 64.14 (OCH2CH2), 56.92 (C-4), 40.21
(C-5), 27.89 (OCH2CH2); (MS-ESI): m/z (M+1)
+ 671; Anal.
Calc. for C41H36O4N4: C, 75.92; H, 5.55; N, 8.64; Found C,
76.20; H, 5.57; N, 8.66%.Please cite this article in press as: M. Yusuf, I. Solanki, Synthesis and antimicrobial
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dihydro-1H-pyrazol-3-yl)phenoxy)-4-(4-((S)-5-(furan-2-yl)-
1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)butane 9c
the compound 9c was synthesized from the reaction of bischal-
cone 8c (1.0 g, 0.002 mol) with phenyl hydrazine (0.44 g,
0.004 mol) under similar conditions as described above for 9a.
9c: Brown solid; Yield 68%; m.p.: 112–114 C; IR (KBr)
cm1: 2922, 2859 (methylene CAH), 1596 (C‚N) & 1249,
1032 (CAO); 1H NMR (400 MHz, DMSO-d6): d 7.67 (4H,
dd, Jm,o = 4.9, 7.8 Hz, H-2
0, 60), 7.39 (2H, d, J300,400 = 0.6 Hz,
H-300), 7.19 (4H, t, J= 8.5 Hz, H-3000, 5000), 7.12 (4H, dt,
Jo = 2.4, 7.8 Hz, H-2
000, 6000), 6.92 (4H, d, Jo = 7.9 Hz, H-30,
50), 6.76 (2H, m, H-500), 6.31 (2H, dt, J= 2.9, 4.4 Hz, H-4000),
6.28 (2H, dd, J400,300 = 1.1 Hz, J400,500 = 2.9 Hz, H-4
00), 5.36
(2H, dd, JXA = 5.4 Hz, JXM = 12.2 Hz, H-X), 3.76 (2H, dd,
JMX = 12.0 Hz, JMA = 16.1 Hz, H-M), 3.66 (2H, dd,
JAX = 7.0 Hz, JAM = 16.2 Hz, H-A), 4.16 (4H, brs,
OCH2CH2), 1.98 (4H, brs, OCH2CH2);
13C NMR (DMSO-
d6): d 159.03 (C-200), 153.06 (C-40), 146.93 (C‚N), 144.62 (C-
1000), 141.76 (C-10), 128.31 (C-20, 60), 126.76 (C-300), 118.48 (C-
3000, 5000), 116.18 (C-500), 114.08 (C-4000), 112.85 (C-30, 50),
109.96 (C-2000, 6000), 106.78 (C-400), 66.96 (OCH2CH2), 57.04
(C-5), 49.06 (C-4), 25.28 (OCH2CH2); (MS-ESI): m/z
(M+1)+ 663; Anal. Calc. for C42H38O4N4: C, 76.13; H,
5.74; N, 8.46; Found C, 75.87; H, 5.77; N, 8.48%.
2.13. Synthesis of 1-(4-((R)-5-(furan-2-yl)-1-phenyl-4,5-
dihydro-1H-pyrazol-3-yl)phenoxy)-5-(4-((S)-5-(furan-2-yl)-
1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)pentane 9d
The compound 9d was prepared by treating bischalcone 8d
(1.0 g, 0.002 mol) with phenyl hydrazine (0.43 g, 0.004 mol)
under similar conditions as described earlier for 9a.
9d: Brown solid; Yield 62%;m.p.: 96–99 C; IR (KBr) cm1:
2938, 2867 (methylene CAH), 1596 (C‚N) & 1245, 1012
(CAO); 1H NMR (400 MHz, DMSO-d6): d 7.65 (4H, d,
Jo = 8.1 Hz, H-2
0, 60), 7.33 (2H, d, J300,400 = 1.5 Hz, H-300), 7.20
(4H, m, H-3000, 5000), 7.10 (4H, m, H-2000, 6000), 6.92 (4H, d,
Jo = 8.1 Hz, H-3
0, 50), 6.86 (2H, d, J500,400 = 3.2 Hz, H-500), 6.73
(2H, m, H-4000), 6.29 (2H, m, H-400), 5.40 (2H, dd, JXA =
6.2 Hz, JXM = 14.4 Hz, H-X), 4.01 (4H, t, Jvic = 6.1 Hz,
OCH2), 3.69 (2H, dd, JMX = 12.4 Hz, JMA = 17.0 Hz, H-M),
3.32 (2H, dd, JAX = 6.3 Hz, JAM = 17.0 Hz, H-A), 1.85 (4H,
quintet, Jvic = 6.5 Hz, OCH2CH2), 1.67 (2H, m,
OCH2CH2CH2);
13C NMR (100 MHz, DMSO-d6): d 159.14
(C-200), 153.13 (C-40), 147.04 (C‚N), 144.63 (C-1000), 141.93 (C-
10), 128.38 (C-20, 60), 126.84 (C-300), 118.45 (C-3000, 5000), 115.68
(C-500), 114.17 (C-4000), 112.87 (C-30, 50), 110.04 (C-2000, 6000),
106.96 (C-400), 67.23 (OCH2), 56.91 (OCH2CH2), 40.13 (C-4),
28.31 (OCH2CH2), 22.09 (OCH2CH2CH2); (MS-ESI): m/z
(M+1)+ 677; Anal. Calc. for C44H42O4N4: C, 76.52; H, 6.08;
N, 8.11; Found C, 76.74; H, 6.10; N, 8.14%.
2.14. Synthesis of 1-(4-((R)-5-(furan-2-yl)-1-phenyl-4,5-
dihydro-1H-pyrazol-3-yl)phenoxy)-6-(4-((S)-5-(furan-2-yl)-
1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)hexane 9e
The compound 9e was synthesized by treating bischalcone 8e
(1.0 g, 0.0019 mol) with phenyl hydrazine (0.42 g,
0.0039 mol) under similar conditions as discussed above for 9a.studies of furyl based new bispyrazolines linked via aliphatic chains, Journal of
Furyl based new bispyrazolines linked via aliphatic chains 59e: Light yellow solid; Yield 59%; m.p.: 122–125 C; IR
(KBr) cm1: 2933, 2867 (methylene CAH), 1596 (C‚N) &
1248, 1014 (CAO); 1H NMR (400 MHz, DMSO-d6): d 7.67
(4H, dd, Jm,o = 1.4, 8.7 Hz, H-2
0, 60), 7.34 (2H, d,
J300,400 = 0.6 Hz, H-3
00), 7.27 (4H, m, H-3000, 5000), 7.17 (4H, dd,
Jm,o = 1.9, 7.8 Hz, H-2
000, 6000), 6.91 (4H, dd, Jm,o = 1.2,
8.7 Hz, H-30, 50), 6.84 (2H, m, H-4000), 6.28 (2H, m, H-500),
6.21 (2H, m, H-400), 5.31 (2H, dd, JXA = 6.8 Hz,
JXM = 11.9 Hz, H-X), 4.02 (4H, t, Jvic = 5.9 Hz, OCH2),
3.70 (2H, dd, JMX = 12.0 Hz, JMA = 16.8 Hz, H-M), 3.36
(2H, dd, JAX = 6.8 Hz, JAM = 16.8 Hz, H-A), 1.85 (4H, quin-
tet, Jvic = 6.2 Hz, OCH2CH2), 1.49 (4H, m, OCH2CH2CH2);
13C NMR (100 MHz, DMSO-d6): d 159.75 (C-200), 153.88 (C-
40), 147.49 (C‚N), 145.40 (C-1000), 142.18 (C-10), 128.88 (C-
20, 60), 127.30 (C-300), 125.21 (C-3000, 5000), 119.26 (C-500), 114.57
(C-4000), 113.61 (C-30, 50), 110.47 (C-2000, 6000), 106.90 (C-400),
67.89 (OCH2), 58.18 (C-5), 48.35 (C-4), 29.16 (OCH2CH2),
25.86 (OCH2CH2CH2); (MS-ESI): m/z (M+1)
+ 713; Anal.
Calc. for C44H42O4N4: C, 76.52; H, 6.08; N, 8.11; Found C,
76.74; H, 6.10; N, 8.14%.
2.15. Synthesis of 1-(4-((R)-5-(furan-2-yl)-1-phenyl-4,5-
dihydro-1H-pyrazol-3-yl)phenoxy)-8-(4-((S)-5-(furan-2-yl)-
1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)octane 9f
The compound 9f was obtained by reacting bischalcone 8f
(1.0 g, 0.0018 mol) with phenyl hydrazine (0.40 g,
0.0037 mol) under similar conditions as used above for 9a.
9f: Light yellow solid; Yield 64%; m.p.: 115–118 C; 1IR
(KBr) cm1: 2933, 2856 (methylene CAH), 1596 (C‚N) &
1250, 1034 (CAO); 1H NMR (400 MHz, DMSO-d6): d 7.66
(4H, d, Jo = 8.6 Hz, H-2
0, 60), 7.50 (2H, d, J300,400 = 3.4 Hz,
H-300), 7.16 (4H, t, J= 8.0 Hz, H-3000, 5000), 7.09 (4H, d,
Jo = 7.8 Hz, H-2
000, 6000), 7.00 (2H, d, J500,400 = 3.6 Hz, H-500),
6.92 (4H, d, Jo = 8.6 Hz, H-3
0, 50), 6.73 (2H, t, J= 8.0 Hz,
H-4000), 6.32 (2H, brs, H-4000), 5.43 (2H, dd, JXA = 5.7 Hz,
JXM = 11.4 Hz, H-X), 4.06 (2H, dd, JMX = 13.6 Hz,
JMA = 17.2 Hz, H-M), 3.99 (4H, t, Jvic = 6.4 Hz, OCH2),
3.72 (2H, dd, JAX = 7.0 Hz, JAM = 17.8 Hz, H-A), 1.78
(4H, quintet, Jvic = 6.5 Hz, OCH2CH2), 1.48 (8H, m,
OCH2CH2CH2CH2);
13C NMR (100 MHz, DMSO-d6): d
159.29 (C-200), 153.30 (C-40), 147.31 (C‚N), 144.27 (C-1000),
140.13 (C-10), 128.88 (C-20, 60), 127.55 (C-300), 124.54 (C-3000,
5000), 118.50 (C-500), 114.35 (C-4000), 112.99 (C-30, 50), 110.20
(C-2000, 6000), 107.23 (C-400), 67.77 (OCH2), 56.85 (C-5), 48.26
(C-4), 28.70 (OCH2CH2), 25.42 (OCH2CH2CH2), 21.42
(OCH2CH2CH2CH2); (MS-ESI): m/z (M+1)
+ 719; Anal.
Calc. for C46H46O4N4: C, 76.88; H, 6.41; N, 7.80; Found C,
77.14; H, 6.38; N, 7.78%.
2.16. Synthesis of 1-(4-((R)-5-(furan-2-yl)-1-phenyl-4,5-
dihydro-1H-pyrazol-3-yl)phenoxy)-10-(4-((S)-5-(furan-2-yl)-
1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)decane 9g
The compound 9g was synthesized from the reaction of bis-
chalcone 8g (1.0 g, 0.0017 mol) with phenyl hydrazine
(0.38 g, 0.0035 mol) under similar conditions as described ear-
lier for 9a.
9g: Brown solid; Yield 65%; m. pt.: 102–104 C; IR (KBr)
cm1: 2936, 2856 (methylene CAH), 1597 (C‚N) & 1248,
1018 (CAO); 1H NMR (400 MHz, DMSO-d6): d 7.67 (4H, d,Please cite this article in press as: M. Yusuf, I. Solanki, Synthesis and antimicrobial s
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0, 60), 7.45 (2H, d, J300,400 = 1.7 Hz, H-300),
7.18 (6H, t, J= 7.8 Hz, H-3000, 4000, 5000), 7.10 (4H, d,
Jo = 8.2 Hz, H-2
000, 6000), 6.94 (4H, d, J= 8.4 Hz, H-30, 50),
6.74 (2H, d, J500,400 = 3.1 Hz, H-5
00), 6.33 (2H, brs, H-400), 5.47
(2H, dd, JXA = 6.2 Hz, JXM = 11.8 Hz, H-X), 4.01 (4H, t,
Jvic = 6.3 Hz, OCH2), 3.75 (2H, dd, JMX = 12.7 Hz,
JMA = 17.0 Hz, H-M), 3.35 (2H, dd, JAX = 6.0 Hz,
JAM = 16.1 Hz, H-A), 1.76 (4H, quintet, Jvic = 6.5 Hz,
OCH2CH2), 1.46 (4H, m, OCH2CH2CH2), 1.39 (8H, m,
OCH2CH2OCH2CH2CH2);
13C NMR (100 MHz, DMSO-
d6): d 159.22 (C-200), 153.29 (C-40), 147.38 (C‚N), 144.57 (C-
1000), 142.07 (C-10), 129.24 (C-20, 60), 127.46 (C-300), 124.72 (C-
3000, 5000), 118.68 (C-5’’), 114.12 (C-4000), 112.96 (C-30, 50),
110.39 (C-2000, 6000), 107.18 (C-400), 67.62 (OCH2), 57.35 (C-5),
42.84 (C-4), 28.79 (OCH2CH2), 25.29 (OCH2CH2CH2), 21.48
(OCH2CH2CH2CH2), 20.84 (OCH2CH2CH2CH2CH2CH2);
(MS-ESI): m/z (M+1)+ 747; Anal. Calc. for C48H50O4N4:
C, 77.21; H, 6.16; N, 7.50; Found C, 77.43; H, 6.18; N, 7.53%.
2.17. Synthesis of 1-(4-((R)-5-(furan-2-yl)-1-phenyl-4,5-
dihydro-1H-pyrazol-3-yl)phenoxy)-12-(4-((S)-5-(furan-2-yl)-
1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)dodecane 9h
The compound 9h was synthesized from the reaction of bis-
chalcone 8h (1.0 g, 0.0016 mol) with phenyl hydrazine
(0.36 g, 0.0033 mol) under similar conditions as discussed
above for 9a.
9h: Light yellow solid; Yield 79%; m.p.: 80–82 C; IR
(KBr) cm1: 2921, 2851 (methylene CAH), 1596 (C‚N) &
1247, 1012 (CAO); 1H NMR (400 MHz, DMSO-d6): d 7.67
(4H, d, Jo = 8.8 Hz, H-2
0, 60), 7.42 (2H, brs, H-300), 7.20
(6H, t, J= 8.5 Hz, H-3000, 4000, 5000), 7.10 (4H, m, H-2000, 6000),
6.92 (4H, dd, J= 3.3, 8.7 Hz, H-30, 50), 6.76 (2H, d, J500,400 =
3.1 Hz, H-500), 6.32 (2H, dd, J400,300 = 1.8, J400,500 = 3.2 Hz, H-
400), 5.41 (2H, dd, JXA = 6.4 Hz, JXM = 11.8 Hz, H-X), 3.98
(4H, t, Jvic = 6.6 Hz, OCH2), 3.70 (2H, dd, JMX = 12.0 Hz,
JMA = 16.8 Hz, H-M), 3.36 (2H, dd, JAX = 6.8 Hz,
JAM = 16.8 Hz, H-A), 1.77 (4H, quintet, Jvic = 6.4 Hz,
OCH2CH2), 1.45 (4H, m, OCH2CH2CH2), 1.30 (4H, m,
OCH2CH2OCH2CH2), 1.24 (8H, m, OCH2CH2OCH2CH2
CH2);
13C NMR (100 MHz, DMSO-d6): d 159.19 (C-200),
153.13 (C-40), 147.04 (C‚N), 144.62 (C-1000), 141.92 (C-10),
130.18 (C-20, 60), 126.82 (C-300), 118.51 (C-3000, 5000), 116.67 (C-
500), 114.12 (C-4000), 112.85 (C-30, 50), 110.02 (C-2000, 6000),
106.94 (C-400), 67.37 (OCH2), 56.88 (C-5), 39.50 (C-4), 28.86
(OCH2CH2), 28.69 (OCH2CH2CH2), 28.55 (OCH2CH2CH2
CH2), 25.37 (OCH2CH2CH2CH2CH2), 20.69 (OCH2CH2CH2
CH2CH2CH2); (MS-ESI): m/z (M+1)
+ 775; Anal. Calc. for
C50H54O4N4: C, 77.52; H, 6.98; N, 7.23; Found C, 77.34; H,
6.95; N, 7.25%.
3. Results and discussion
3.1. Chemistry
Bispyrazolines 9(a–h) required for the present study were syn-
thesized starting from the Claisen–Schmidt condensation reac-
tion of p-hydroxyacetophenone 6 with 2-furfuraldehyde to
yield chalcone 7. The latter were then O-alkylated with different
1,x-dibromoalkanes (1,2-dibromoethane, 1,3-di-
bromopropane, 1,4-dibromobutane, 1,5-dibromopentane, 1,6-tudies of furyl based new bispyrazolines linked via aliphatic chains, Journal of
6 M. Yusuf, I. Solankidibromohexane, 1,8-dibromooctane, 1,10-dibromodecane &
1,12-dibromododecane) in the presence of anhydrous K2CO3,
dry acetone and Bu4N
+I (PTC) to obtain bischalcones 8(a–
h) in goodyield.Thebischalconeswere further cyclizedwith phe-
nyl hydrazine in dry EtOH (25 mL) and glacial AcOH (5 mL) to
yield bispyrazolines 9(a–h) (Scheme 1). The intermediate bis-
chalcones andﬁnal bisheterocycleswere puriﬁed by their crystal-
lization using MeOH as solvent. The structures of the newly
prepared compounds were conﬁrmed from the rigorous analysis
of their IR, 1H NMR, 13C NMR and mass spectral data. The
purity of these compounds was very well supported by their
satisfactory elemental analysis results.
IR spectrum of chalcone 7 exhibited major absorptions at
3260 (OH), 1656 (C‚O) & 1604 cm1 (C‚C). Its 1H NMR
spectrum (400 MHz, CDCl3) showed a D2O exchangeable
broad singlet at d 10.11 due to OH group. The protons of
the double bond were very well resonating at d 7.53 (1H, d,
Jtrans = 15.3 Hz, H-3) & 7.47 (1H, d, Jtrans = 15.4 Hz, H-2).
The furyl ring protons and p-disubstituted benzene ring pro-
tons were found to be placed in the aromatic region at their
appropriate positions (vide experimental). Finally, structure
was conﬁrmed from its 13C NMR spectrum which displayed
the major resonances at d 195.74 (C‚O), 145.45 (C-3) &
115.37 (C-2) and other downﬁeld signals were found to be
placed in the aromatic region at d 162.13 (C-200) & 151.28
(C-40) due to their placement adjacent to electronegative oxy-
gen atoms. The remaining signals were present at their
expected positions in the aromatic region (vide experimental).
In the IR spectra of compounds 8(a–h), strong absorption
bands were observed at 1659–1652 cm1 and 1605–
1597 cm1 which are easily assigned to the conjugated C‚O
and C‚C group respectively and other noticeable bands were
also observed at 2955–2850 (methylene CAH) and 1255–
1010 cm1 (CAO). The band at 3260 cm1 in IR and a singlet
at d 10.11 in 1H NMR spectrum of chalcone 7 were found to be
absent in the corresponding bischalcones 8(a–h) which showed
that O-alkylation reactions have taken place.
1H NMR spectra (400 MHz, CDCl3) of bischalcones 8(a–h)
were quite informative and noticeable signals in the form of
two broad doublets were present at d 7.56–7.52 & 7.50–7.47
due to the protons H-3 & H-2 respectively and the trans
geometry of these hydrogens was conﬁrmed from their vicinal
coupling constant (J2,3 = 15.4–15.3 Hz). The slight downﬁeld
placement of the former could be explained on the basis of
its b-position in the enone moiety which is considered to be
electron deﬁcient in nature. The furyl ring protons H-300, H-
500 & H-400 were resonating at d 7.79–7.51 (2H, d,
J300,400 = 1.5–1.3 Hz), 6.92–6.69 (2H, d, J500,400 = 3.4 Hz) &
6.62–6.50 (2H, dd, J400,300 = 1.8–1.7 Hz, J400,500 = 3.5–3.2 Hz)
respectively. The p-disubstituted benzene ring protons H-20,
60 & H-30, 50 produced two doublets of doublets integrating
for four hydrogens each at d 8.05–8.01 (Jm,o = 2.9–2.6, 8.8–
8.7 Hz) & 7.08–6.92 (Jm,o = 2.6, 8.8–8.6 Hz) respectively.
The protons belonging to internal aliphatic chain appeared
in the aliphatic region at d 4.47–3.98 (OCH2) and 2.27–1.24
{OCH2(CH2)n} and downﬁeld resonance of the former could
be ascribed to its presence near to the electronegative oxygen
atom (Figure 2).
13C NMR spectra (100 MHz, CDCl3) of 8(a–h) revealed the
most downﬁeld signal at d 188.08–186.57 which may be allot-
ted to C‚O group of the enone moiety. Other downﬁeld sig-
nals located at d 163.67–162.06 and 151.87–151.04 could bePlease cite this article in press as: M. Yusuf, I. Solanki, Synthesis and antimicrobial
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electronegative oxygen atoms. The double bond carbon atom
C-3 & C-2 could appear at d 145.45–144.66 & 114.38–113.78
respectively. The remaining signals in the aromatic region were
found to be placed at d 132.47–130.15 (C-20, 60), 130.74–130.04
(C-10), 129.99–129.32 (C-300), 119.26–118.15 (C-500), 116.01–
115.61 (C-30, 50) & 112.64–112.37 (C-400). In the upﬁeld region
of the spectrum, internal spacer methylene groups generated
appropriate signals at d 69.64–69.58 (OCH2) and 29.28–21.12
(CH2)n; the downﬁeld resonance of the former again suggests
its close proximity to electronegative oxygen atom.
IR spectra of 9(a–h) were very helpful to corroborate their
structures which did not exhibit any absorption at 1659–
1652 cm1 indicating the involvement of the carbonyl group
during the cyclization of 8(a–h). In spite of this, a signiﬁcant
absorption band was observed at 1597–1596 cm1 due to
C‚N group of the pyrazoline moiety.
In the 400 MHz (DMSO-d6)
1H NMR spectra of
bispyrazolines 9(a–h), resonances H-3 & H-2 of double bonds
present in 8(a–h) were found to be missing altogether which
clearly indicates the involvement of these hydrogens during
the chemical transformation. The signiﬁcant feature of these
spectra was the signals of the pyrazoline ring protons (H-X,
H-M & H-A) which were clearly resonating as three distinctive
doublets of doublets at d 5.49–5.31, 4.06–3.69 & 3.36–3.32
integrating for two hydrogens each. The vicinal coupling con-
stant (3J) between H-X and H-M was found to be 14.4–11.2
which reﬂects that these hydrogens are cis to each other while
coupling value JXA = 6.8–6.0 Hz and JMA = 17.0–16.1 Hz
describes the trans relationship between H-X and H-M
whereas H-M and H-A are geminally placed at C-40. Here,
the aromatic ring protons H-20, 60 & H-30, 50 were centered
at d 7.68–7.65 (4H, dd, Jm,o = 4.9, 8.8 Hz) and 7.00–6.92
(4H, dd, Jm,o = 3.2–1.2, 8.7–7.9 Hz) whereas furanyl ring pro-
tons H-300, H-500 & H-400 were resonating at d 7.49–7.33 (2H,
brs), 7.00–6.86 (2H, m) & 6.38–6.21 (4H, m) respectively.
The protons of N-phenyl ring were also placed at their appro-
priate positions in the aromatic region (vide experimental). In
the aliphatic region, a broad singlet or triplet with coupling
constant of 6.8–6.3 Hz was also observed at d 4.21–3.98 which
may be assigned to the OCH2 group of aliphatic linker whereas
other methylene groups were located at d 2.23–1.24 with
appropriate multiplicities (vide experimental).
The carbon framework of the compounds 9(a-h) were fully
explained on the basis of their 13C NMR spectra (100 MHz,
DMSO-d6). The downﬁeld resonances at d 159.75–159.03,
153.88–153.06, 147.49–146.93 and 145.40–144.62 could be
assigned to C-200, C-40, C‚N & C-1000 due to their direct link-
age to the electronegative atom (O & N). Other resonances in
the aromatic region were placed at d 142.18–141.76, 130.18–
128.31, 127.55–126.76, 125.21–118.45, 119.26–115.68,
116.67–114.08, 114.39–112.85, 110.28–109.96, 107.23–106.90
which could be assigned to C-10, C-20, 60, C-300, C-3000, 5000,
C-500, C-400, C-30, 50, C-2000, 6000 and C-400 respectively. The sig-
nals at d 58.81–55.79 and 49.06–39.50 were easily resulted by
pyrazoline ring carbon C-5 & C-4 respectively and the down-
ﬁeld placement of the former as compared to latter can be
explained on the basis of its benzylic nature and its placement
adjacent to nitrogen atom. The signals placed in the upﬁeld
region at d 67.89–64.14 and 27.89–20.56 were assignable to
intermediate unit OCH2 and (CH2)n group respectively
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Figure 1 Examples of drugs containing pyrazole moiety.
Furyl based new bispyrazolines linked via aliphatic chains 73.2. Antimicrobial activity
All the newly prepared compounds 8(a–h) and 9(a–h) were also
screened for the antibacterial and antifungal activities against
seven bacterial and ﬁve fungal strains namely Escherichia coli,
Pseudomonas aeruginosa, Klebsiella pneumonia, Pseudomonas
ﬂuorescens, Bacillus subtilis, Staphylococcus aureus,
Staphylococcus pyrogen and Fusarium oxysporum, Aspergillus
sclerotium, Aspergillus niger, Penicillium glabrum, Aspergillus
janus respectively. The minimum inhibitory concentrationPlease cite this article in press as: M. Yusuf, I. Solanki, Synthesis and antimicrobial s
Saudi Chemical Society (2015), http://dx.doi.org/10.1016/j.jscs.2015.02.002(MIC) of these synthesized compounds were screened in vitro
by using the serial tube dilution method at concentration
128, 64, 32, 16, 8 and 4 lg/mL against the above said microor-
ganisms. The bacterial strains were subcultured on nutrient
agar medium whereas fungal strains were subcultured on malt
extract medium. The bacterial and fungal strains were incu-
bated at 37 C and 28 C. DMSO was used as a negative con-
trol while Amoxicillin and Fluconazole were used as reference
drugs for comparison. The minimum inhibitory concentrations
(MIC) of all the studied compounds were noted by thetudies of furyl based new bispyrazolines linked via aliphatic chains, Journal of
Figure 2 Partial 1H NMR (400 MHz) spectrum of bischalcone 8b showing aromatic protons (H-20, 60; H-300; H-30, 50; H-500 & H-40) and
double bond protons (H-3 & H-2).
Figure 3 Partial 1H NMR (400 MHz) spectrum of bispyrazoline 9b showing HX, HM and HA including protons of aliphatic chain.
8 M. Yusuf, I. Solankiappearance of turbidity in test tubes after incubation. The
results of the MIC determinations of these compounds have
been presented in Table 1 {8(a–h)} and Table 2 {9(a–h)}.
It is evident from Table 1 that compounds 8a & 8f exhibited
signiﬁcant activities against S. pyrogen& A. sclerotium, P. glab-
rum respectively at MIC of 8 lg/mL whereas compound 8h was
found to be more active against P. ﬂuorescens at MIC of 4 lg/
mL which is comparable to standard drug Amoxicillin.Please cite this article in press as: M. Yusuf, I. Solanki, Synthesis and antimicrobial
Saudi Chemical Society (2015), http://dx.doi.org/10.1016/j.jscs.2015.02.002Table 2 clearly describes that some of the bispyrazolines
exhibited moderate to good activity against the tested antimi-
crobial strains. Compounds 9b & 9d inhibited the growth of P.
ﬂuorescens & A. sclerotium at MIC of 8 lg/mL respectively.
The compounds 9b, 9e and 9f were found to be signiﬁcantly
active against B. subtilis. Compound 9h could provide most
signiﬁcant (MIC-4 lg/mL) against Pseudomonas ﬂuorescens
which is equal to standard drug used.studies of furyl based new bispyrazolines linked via aliphatic chains, Journal of
Table 1 In vitro MIC (lg/mL) of bischalcones 8(a–h).
Compound No. Gram () bacteria Gram (+) bacteria Fungi
E. coli P. aeruginosa K. pneumoniae P. ﬂuorescens B. subtilis S. aureus S. pyrogen F. oxysporum A. sclerotium A. niger P. glabrum A. janus
8a 16 16 16 16 16 16 8 16 16 16 16 16
8b 16 16 32 16 16 32 32 32 32 32 16 32
8c 16 16 32 32 16 32 32 32 32 32 32 32
8d 16 16 16 16 16 32 32 32 32 32 32 16
8e 16 16 32 16 32 16 32 32 32 32 32 32
8f 16 16 32 16 16 32 16 32 8 32 8 16
8g 16 16 32 16 16 32 32 16 16 16 16 32
8h 16 16 32 4 16 16 16 16 16 32 16 16
Amoxicillin 4 4 4 4 2 2 4 – – – – –
Fluconazole – – – – – – – 2 2 2 2 2
Table 2 In vitro MIC (lg/mL) of bispyrazolines 9(a–h).











A. niger P. glabrum A. janus
9a 16 16 16 16 16 16 16 16 16 16 16 16
9b 16 16 16 8 8 16 16 32 16 32 16 16
9c 16 16 32 32 16 32 32 16 16 16 16 16
9d 16 16 16 16 16 32 32 16 8 32 16 16
9e 16 16 32 16 8 16 32 16 16 16 16 16
9f 16 8 32 16 8 32 16 16 16 16 16 16
9g 16 16 32 16 16 32 32 16 16 16 16 16
9h 16 16 32 4 16 16 16 16 16 16 16 16
Amoxicillin 4 4 4 4 2 4 4 – – – – –




















































































































10 M. Yusuf, I. SolankiSo, it is clear from Tables 1 and 2 that most of the synthe-
sized compounds showed moderate to signiﬁcant activities
against the tested microorganisms. The compounds 8a, 8f,
8h, 9b, 9e, 9f & 9h were found to be promising antimicrobial
agents.
4. Conclusion
This study provides the general method for the preparation of
new bispyrazolines linked through alkyl chains of varying
length. The products have been obtained under the normal
conditions without using any speciﬁc and toxic reagent. The
antimicrobial analysis of the prepared bischalcones and
bispyrazolines has also been carried out and newly prepared
compounds 8h & 9h showed most signiﬁcant results (MIC–
4 lg/mL) against P. ﬂuorescens which is comparable to stan-
dard drug. Further investigations regarding the more biologi-
cal studies of these compounds could be helpful in designing
the potent antimicrobial agents.
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